Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Controlled_substance_category
|
| gptkbp:abusePotential |
Lowest among scheduled substances
|
| gptkbp:contrastsWith |
gptkb:Schedule_III_substances
gptkb:Schedule_II_substances gptkb:Schedule_IV_substances gptkb:Schedule_I_substances |
| gptkbp:country |
gptkb:United_States
|
| gptkbp:criteria |
Accepted medical use in the United States
Limited physical or psychological dependence relative to Schedule IV |
| gptkbp:definedIn |
gptkb:Controlled_Substances_Act
|
| gptkbp:example |
gptkb:Lomotil
gptkb:Motofen gptkb:Parepectolin gptkb:Lyrica cough preparations with less than 200 mg codeine per 100 ml |
| gptkbp:legalStatus |
Prescription only (in the US)
|
| gptkbp:regulates |
gptkb:United_States_Drug_Enforcement_Administration
|
| gptkbp:scheduleNumber |
V
|
| gptkbp:bfsParent |
gptkb:21_U.S.C._§_812
gptkb:21_U.S.C._§_841 gptkb:21_U.S._Code_§_829 gptkb:21_U.S._Code_§_841 |
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Schedule V substances
|